ClinicalTrials.Veeva

Menu
C

Clinical Research Center of Reading, LLC | Wyomissing, PA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Baricitinib
Tocilizumab
LY3016859
LY3556050
Filgotinib
Tofacitinib
LY3009104
Tirabrutinib
Methotrexate
Ocrelizumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 41 total trials

A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain (CPMP)

The purpose of the chronic pain master protocol is to compare independent pain interventions and establish an overarching structure for the disease-s...

Enrolling
Chronic Low-back Pain
Diabetic Neuropathic Pain
Drug: LY3016859 ISA
Drug: Placebo Oral

This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous throm...

Active, not recruiting
Rheumatoid Arthritis
Drug: Baricitinib
Drug: TNF Inhibitor

The primary objective of this study is to evaluate the long-term safety and tolerability of filgotinib in participants who have completed one of the...

Active, not recruiting
Rheumatoid Arthritis
Drug: Filgotinib
Drug: Placebo to match filgotinib

Trial sponsors

Lilly logo
Pfizer logo
Roche logo
Bristol-Myers Squibb (BMS) logo
Genentech logo
Gilead Sciences logo
Merck KGaA (EMD Serono) logo
C
C
G

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems